These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32030262)

  • 1. NF-κB1 promoter-94ins/delATTG polymorphisms correlate with the acute exacerbation of chronic obstructive pulmonary disease.
    Meng X; Zheng SQ; Wang JH; Zhang T
    J Thorac Dis; 2019 Dec; 11(12):5433-5439. PubMed ID: 32030262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NFKB1 promoter -94 insertion/deletion ATTG polymorphism (rs28362491) is associated with severity and disease progression of rheumatoid arthritis through interleukin-6 levels modulation in Egyptian patients.
    Elkhawaga SY; Gomaa MH; Elsayed MM; Ebeed AA
    Clin Rheumatol; 2021 Jul; 40(7):2927-2937. PubMed ID: 33459954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of NF-kappaB1 and NF-kappaBIAlpha polymorphisms using PCR-RFLP assay in a Turkish population.
    Senol Tuncay S; Okyay P; Bardakci F
    Biochem Genet; 2010 Feb; 48(1-2):104-12. PubMed ID: 19941056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between the
    Chen J; Ge D; Xiong Y
    Clin Exp Hypertens; 2019; 41(6):577-582. PubMed ID: 30285510
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk association between the NF-κB1 -94ins/delATTG promoter polymorphism and inflammatory bowel diseases: a meta-analysis.
    Liang M; Xu X; Gong Y; Tang Y; Lin L
    Dig Dis Sci; 2012 Sep; 57(9):2304-9. PubMed ID: 22828805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The
    Nowak H; Vornweg S; Rump K; Rahmel T; Unterberg M; Koos B; Schenker P; Viebahn R; Adamzik M; Bergmann L
    Cells; 2021 Feb; 10(2):. PubMed ID: 33673169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hydrocortisone fails to abolish NF-κB1 protein nuclear translocation in deletion allele carriers of the NFKB1 promoter polymorphism (-94ins/delATTG) and is associated with increased 30-day mortality in septic shock.
    Schäfer ST; Gessner S; Scherag A; Rump K; Frey UH; Siffert W; Westendorf AM; Steinmann J; Peters J; Adamzik M
    PLoS One; 2014; 9(8):e104953. PubMed ID: 25133403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The NFKB1 promoter polymorphism (-94ins/delATTG) alters nuclear translocation of NF-κB1 in monocytes after lipopolysaccharide stimulation and is associated with increased mortality in sepsis.
    Adamzik M; Schäfer S; Frey UH; Becker A; Kreuzer M; Winning S; Frede S; Steinmann J; Fandrey J; Zacharowski K; Siffert W; Peters J; Hartmann M
    Anesthesiology; 2013 Jan; 118(1):123-33. PubMed ID: 23249930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of NF-κB1 and NF-κBIA gene polymorphism in non-small cell lung cancer.
    Oltulu YM; Coskunpinar E; Ozkan G; Aynaci E; Yildiz P; Isbir T; Yaylim I
    Biomed Res Int; 2014; 2014():530381. PubMed ID: 24707489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meta-analysis of studies on the association between the NF-κB1-94ins/del ATTG promoter polymorphism and cancer.
    Nian X; Zhang W; Li L; Sun Y; Sun E; Han R
    Tumour Biol; 2014 Dec; 35(12):11921-31. PubMed ID: 25190017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of NFKB1 -94ins/delATTG promoter polymorphism with susceptibility to autoimmune and inflammatory diseases: a meta-analysis.
    Zou YF; Wang F; Feng XL; Tao JH; Zhu JM; Pan FM; Su H
    Tissue Antigens; 2011 Jan; 77(1):9-17. PubMed ID: 21155719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphism of the NFKB1 affects the serum inflammatory levels of IL-6 in Hashimoto thyroiditis in a Turkish population.
    Koc A; Batar B; Celik O; Onaran I; Tasan E; Sultuybek GK
    Immunobiology; 2014 Jul; 219(7):531-6. PubMed ID: 24703107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of IL-6, IL-10 and NF-κB Gene Polymorphisms in Aggressive and Chronic Periodontitis.
    Toker H; Görgün EP; Korkmaz EM
    Cent Eur J Public Health; 2017 Jun; 25(2):157-162. PubMed ID: 28662328
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in Toll-like receptor and nuclear factor-kappa B genes and the risk of glioma.
    Kına I; Sultuybek GK; Soydas T; Yenmis G; Biceroglu H; Dirican A; Uzan M; Ulutin T
    Br J Neurosurg; 2019 Apr; 33(2):165-170. PubMed ID: 30450997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The functional 4-bp insertion/deletion ATTG polymorphism in the promoter region of NF-KB1 reduces the risk of BC.
    Eskandari-Nasab E; Hashemi M; Ebrahimi M; Amininia S
    Cancer Biomark; 2016; 16(1):109-15. PubMed ID: 26835711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the NFKB1 -94ins/delATTG promoter polymorphism in IBD and potential interactions with polymorphisms in the CARD15/NOD2, IKBL, and IL-1RN genes.
    Glas J; Török HP; Tonenchi L; Müller-Myhsok B; Mussack T; Wetzke M; Klein W; Epplen JT; Griga T; Schiemann U; Lohse P; Seiderer J; Schnitzler F; Brand S; Ochsenkühn T; Folwaczny M; Folwaczny C
    Inflamm Bowel Dis; 2006 Jul; 12(7):606-11. PubMed ID: 16804398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Pro-Inflammatory Deletion Allele of the NF-κB1 Polymorphism Is Characterized by a Depletion of Subunit p50 in Sepsis.
    Marko B; Heurich P; Thon P; Zimmer F; Bergmann L; Nowak H; Rump K; Koos B; Adamzik M; Unterberg M; Rahmel T
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contributions of NFKB1 -94insertion/deletion ATTG polymorphism to the susceptibility of gastrointestinal cancers: A meta-analysis.
    Wu H; Liang J
    J Cell Mol Med; 2021 Nov; 25(22):10674-10683. PubMed ID: 34672421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Study of Nuclear Factor-Kappa B1 Gene Polymorphism Types in Schizophrenia Patients and Their Correlation With Disease Severity.
    Swain SA; Sarangi P; Rattan R; Sahu PK; Lamare AA
    Cureus; 2022 Apr; 14(4):e24401. PubMed ID: 35619863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PDGFRα promoter polymorphisms and expression patterns influence risk of development of imatinib-induced thrombocytopenia in chronic myeloid leukemia: A study from India.
    Guru SA; Mir R; Bhat M; Najar I; Zuberi M; Sumi M; Masroor M; Gupta N; Saxena A
    Tumour Biol; 2017 Oct; 39(10):1010428317713857. PubMed ID: 29019285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.